TrialDiabetes care2018

Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA

Robert R Henry et al.PubMed ↗Publisher ↗

No numbers read from the abstract.